You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

HYDROCORTISONE VALERATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Hydrocortisone Valerate patents expire, and what generic alternatives are available?

Hydrocortisone Valerate is a drug marketed by Cosette, Encube Ethicals, Glenmark Pharms Ltd, Lupin Ltd, Padagis Israel, Taro, and Fougera Pharms. and is included in eleven NDAs.

The generic ingredient in HYDROCORTISONE VALERATE is hydrocortisone valerate. There are sixty-seven drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the hydrocortisone valerate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Hydrocortisone Valerate

A generic version of HYDROCORTISONE VALERATE was approved as hydrocortisone valerate by TARO on August 25th, 1998.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for HYDROCORTISONE VALERATE?
  • What are the global sales for HYDROCORTISONE VALERATE?
  • What is Average Wholesale Price for HYDROCORTISONE VALERATE?
Drug patent expirations by year for HYDROCORTISONE VALERATE
Drug Prices for HYDROCORTISONE VALERATE

See drug prices for HYDROCORTISONE VALERATE

Pharmacology for HYDROCORTISONE VALERATE
Anatomical Therapeutic Chemical (ATC) Classes for HYDROCORTISONE VALERATE
A01AC Corticosteroids for local oral treatment
A01A STOMATOLOGICAL PREPARATIONS
A01 STOMATOLOGICAL PREPARATIONS
A Alimentary tract and metabolism
A07EA Corticosteroids acting locally
A07E INTESTINAL ANTIINFLAMMATORY AGENTS
A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS
A Alimentary tract and metabolism
C05AA Corticosteroids
C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
C05 VASOPROTECTIVES
C Cardiovascular system
D07AA Corticosteroids, weak (group I)
D07A CORTICOSTEROIDS, PLAIN
D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS
D Dermatologicals
D07XA Corticosteroids, weak, other combinations
D07X CORTICOSTEROIDS, OTHER COMBINATIONS
D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS
D Dermatologicals
H02AB Glucocorticoids
H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
H02 CORTICOSTEROIDS FOR SYSTEMIC USE
H Systemic hormonal preparations, excluding sex hormones and insulins
H02AB Glucocorticoids
H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
H02 CORTICOSTEROIDS FOR SYSTEMIC USE
H Systemic hormonal preparations, excluding sex hormones and insulins
S01BA Corticosteroids, plain
S01B ANTIINFLAMMATORY AGENTS
S01 OPHTHALMOLOGICALS
S Sensory organs
S01BA Corticosteroids, plain
S01B ANTIINFLAMMATORY AGENTS
S01 OPHTHALMOLOGICALS
S Sensory organs
S01CB Corticosteroids/antiinfectives/mydriatics in combination
S01C ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION
S01 OPHTHALMOLOGICALS
S Sensory organs
S02BA Corticosteroids
S02B CORTICOSTEROIDS
S02 OTOLOGICALS
S Sensory organs

US Patents and Regulatory Information for HYDROCORTISONE VALERATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cosette HYDROCORTISONE VALERATE hydrocortisone valerate CREAM;TOPICAL 074489-001 Aug 12, 1998 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Taro HYDROCORTISONE VALERATE hydrocortisone valerate CREAM;TOPICAL 075042-001 Aug 25, 1998 AB RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Glenmark Pharms Ltd HYDROCORTISONE VALERATE hydrocortisone valerate CREAM;TOPICAL 211129-001 Oct 12, 2018 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Cosette HYDROCORTISONE VALERATE hydrocortisone valerate OINTMENT;TOPICAL 211764-001 Mar 4, 2020 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Cosette HYDROCORTISONE VALERATE hydrocortisone valerate CREAM;TOPICAL 213724-001 Feb 11, 2021 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Encube Ethicals HYDROCORTISONE VALERATE hydrocortisone valerate CREAM;TOPICAL 211047-001 Nov 4, 2021 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.